1 – 18 of 18
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Move over Tregs, MDSCs are here
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
C-reactive protein boosts antibody-mediated platelet destruction
(
- Contribution to journal › Scientific review
-
Mark
Back to the Present
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Chasing flies because time flies
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Response to: 'Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis' by Ellerby et al
(
- Contribution to journal › Letter
-
Mark
Neurodegenerative disease : Mapping the natural history of Huntington disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Platelet GPIb-IX has suppressive effects on septic inflammation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Central Clock in Patients With Parkinson Disease — Reply
(
- Contribution to journal › Letter
- 2013
-
Mark
Editor's commentary
(
- Contribution to journal › Article
-
Mark
Platelets deliver small packages of genetic function
(
- Contribution to journal › Debate/Note/Editorial
- 2012
-
Mark
Bregging rights in ITP
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Geriatrikundervisningens omfattning - avgörande för framtidens sjukvård
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
ITP has elevated BAFF expression
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Processed platelet HPA1a peptides au naturel
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Platelet antigen-induced regulation in ITP
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Bacterial proteases disarming host defense
(
- Contribution to journal › Debate/Note/Editorial
- 2008
-
Mark
ITP three R's : regulation, routing, rituximab
(
- Contribution to journal › Article
- 1997
-
Mark
The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy
(
- Contribution to journal › Debate/Note/Editorial